{"id":149,"date":"2018-10-15T13:39:50","date_gmt":"2018-10-15T11:39:50","guid":{"rendered":"http:\/\/www.pharmin.sk\/?p=149"},"modified":"2018-10-22T14:04:58","modified_gmt":"2018-10-22T12:04:58","slug":"nova-publikacia-vybrane-epidemiologicke-aspekty-maligneho-melanomu-koze","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/nova-publikacia-vybrane-epidemiologicke-aspekty-maligneho-melanomu-koze\/","title":{"rendered":"Vybran\u00e9 epidemiologick\u00e9 aspekty mal\u00edgneho melan\u00f3mu ko\u017ee"},"content":{"rendered":"

Autori: Ondru\u0161ov\u00e1, M., Suchansk\u00fd, M., Kuraj, J.<\/p>\n

Mal\u00edgny melan\u00f3m vznik\u00e1 naj\u010dastej\u0161ie v ko\u017ei, ale m\u00f4\u017ee by\u0165 lokalizovan\u00fd kdeko\u013evek v tele. Napriek tomu, \u017ee na ko\u017ei tvor\u00ed len mal\u00fa \u010das\u0165 zo v\u0161etk\u00fdch zhubn\u00fdch n\u00e1dorov, je z nich najagres\u00edvnej\u0161\u00ed a pre vysok\u00fa r\u00fdchlos\u0165 tvorby metast\u00e1z je pr\u00ed\u010dinou 75 % \u00famrt\u00ed na malignity tejto topografickej lokaliz\u00e1cie. Incidencia glob\u00e1lne v\u00fdrazne var\u00edruje a r\u00fdchlo rastie, predov\u0161etk\u00fdm vo vysoko rozvinut\u00fdch krajin\u00e1ch.<\/p>\n

Predkladan\u00e1 recenzovan\u00e1 publik\u00e1cia poskytuje na Slovensku jedine\u010dn\u00e9 a komplexn\u00e9 inform\u00e1cie o v\u0161etk\u00fdch dostupn\u00fdch deskript\u00edvnych epidemiologick\u00fdch ukazovate\u013eoch mal\u00edgneho melan\u00f3mu ko\u017ee na Slovensku. V preh\u013eadn\u00fdch tabu\u013ek\u00e1ch a grafoch s interpret\u00e1ciami prezentuje nasledovn\u00e9 \u201ehard-data\u201c z n\u00e1rodn\u00fdch datab\u00e1zov\u00fdch syst\u00e9mov a predikcie do aktu\u00e1lnych rokov:<\/p>\n

Z\u00e1kladn\u00e9 epidemiologick\u00e9 ukazovatele mal\u00edgneho melan\u00f3mu ko\u017ee, ktor\u00e9 zah\u0155\u0148aj\u00fa h\u013abkov\u00fa anal\u00fdzu incidencie, mortality, prevalencie, klinick\u00fdch \u0161t\u00e1di\u00ed a vekov\u00fdch charakterist\u00edk pacientov na SlovenskuOdhad ve\u013ekosti celkovej cie\u013eovej popul\u00e1cie pacientov s metastatick\u00fdm, BRAF+ a BRAF- melan\u00f3mom ko\u017ee v SR pre r. 2018H\u013abkov\u00fa anal\u00fdzu datab\u00e1zy \u201e\u00dahrady zdravotn\u00fdch pois\u0165ovn\u00ed pod\u013ea vekov\u00fdch skup\u00edn a diagn\u00f3z\u201c za rok 2016Po\u010dty lie\u010den\u00fdch pacientov s mal\u00edgnym melan\u00f3mom ko\u017ee v SR pod\u013ea \u00fadajov NCZIAnal\u00fdzu datab\u00e1z \u201eIndividualizovan\u00e9 d\u00e1ta o \u00fahrad\u00e1ch zdravotn\u00fdch pois\u0165ovn\u00ed za lieky (r. 2015\u20122017) a za \u00fastavn\u00fa zdravotn\u00fa starostlivos\u0165 (r. 2015, 2016)\u201cDopl\u0148uj\u00face nad\u0161tandardn\u00e9 \u00fadaje z NCZI o celkovom po\u010dte vy\u0161etren\u00fdch pacientov s mal\u00edgnym melan\u00f3mom ko\u017ee v SR v r. 2017 (pod\u013ea zadefinovan\u00fdch krit\u00e9ri\u00ed)<\/p>\n

Publik\u00e1cia je plne citovate\u013en\u00e1 (s vlastn\u00fdm ISBN), jej s\u00fa\u010das\u0165ou je \u0161trukt\u00farovan\u00fd abstrakt vhodn\u00fd napr. do farmakoekonomick\u00e9ho rozboru a pre \u00fa\u010dely v\u00fdpo\u010dtu cie\u013eovej popul\u00e1cie pacientov, ktor\u00fd je transponibiln\u00fd aj pre in\u00e9 (\u0161pecifick\u00e9) stavy v s\u00falade napr. s platn\u00fdmi indik\u00e1ciami lie\u010div. Publik\u00e1cia m\u00e1 80 str\u00e1n, vyjadrenie recenzenta tvor\u00ed jej pr\u00edlohu.<\/p>\n

Report bude na vy\u017eiadanie poskytnut\u00fd \u0161t\u00e1tnym autorit\u00e1m v oblasti hodnotenia zdravotn\u00edckych technol\u00f3gi\u00ed (MZ SR a zdravotn\u00e9 pois\u0165ovne) z d\u00f4vodu zabezpe\u010denia dostupnosti sum\u00e1rnych epidemiologick\u00fdch d\u00e1t o mal\u00edgnom melan\u00f3me v SR.<\/p>\n

V pr\u00edpade \u017ee m\u00e1te z\u00e1ujem o predkladan\u00fa publik\u00e1ciu alebo podobn\u00fa anal\u00fdzu deskript\u00edvnych epidemiologick\u00fdch ukazovate\u013eov pri akejko\u013evek inej diagn\u00f3ze,\u00a0kontaktujte n\u00e1s<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Autori: Ondru\u0161ov\u00e1, M., Suchansk\u00fd, M., Kuraj, J. Mal\u00edgny melan\u00f3m vznik\u00e1 naj\u010dastej\u0161ie v ko\u017ei, ale m\u00f4\u017ee by\u0165 lokalizovan\u00fd kdeko\u013evek v tele. Napriek tomu, \u017ee na ko\u017ei tvor\u00ed len mal\u00fa \u010das\u0165 zo v\u0161etk\u00fdch zhubn\u00fdch n\u00e1dorov, je z nich najagres\u00edvnej\u0161\u00ed a pre vysok\u00fa r\u00fdchlos\u0165 tvorby metast\u00e1z je pr\u00ed\u010dinou 75 % \u00famrt\u00ed na malignity tejto topografickej lokaliz\u00e1cie. Incidencia glob\u00e1lne<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-149","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=149"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/149\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}